ProfileGDS4459 / ENSG00000178137
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 40% 39% 54% 70% 53% 31% 43% 45% 43% 44% 56% 52% 47% 57% 43% 37% 33% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.0840
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.0539
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.5654
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.2470
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.5153
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.7131
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.1543
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 84.1745
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.0943
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.2144
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.5256
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.4552
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.347
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.6457
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.0643
GSM623479group B, liver allograft wedge biopsie placebo treatment 6437
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.8433